Esmolol test to spot heart problems in diabetes, cirrhosis, and cancer
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether esmolol (a short-acting heart medicine) can help doctors identify certain heart-related problems in people with type 2 diabetes, liver scarring (cirrhosis), or specific cancers. It’s mainly about improving how heart issues are detected during ultrasound testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You do not have known moderate-to-severe heart structure or valve problems (no prior old heart attack, certain serious rhythm or contraction issues).
- You have a good ultrasound window, so doctors can see most parts of the heart muscle (at least 14 of 17 areas).
- Your heart rhythm is a normal sinus rhythm with a resting heart rate above 50 beats per minute.
- You fit one of these groups: type 2 diabetes (with or without certain stable heart failure), cirrhosis with specific liver severity, or one of several early cancer diagnoses with planned chemotherapy.
- You can expect to live more than 6 months and be willing to follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two heart medications, carvedilol and empagliflozin, to see if they improve heart function in people with cirrhosis (liver scarring). It might help those who have early signs of heart stiffness but normal pumping strength.
This study tests if giving a fast-acting heart medication (esmolol) early through an IV can protect the heart muscle during a heart attack. It may help patients who cannot receive a standard treatment due to certain risks.
This trial tests if esmolol, a heart-slowing drug, can improve oxygen levels in patients with acute respiratory distress syndrome (ARDS) who are on a breathing machine. It may help by adjusting heart rate to a specific range.
This trial tests whether a low dose of esmolol (a short-acting heart-rate medicine) can reduce heart muscle injury after non-heart surgery in older, frail people. It may help lower the chance of heart-related complications around the time of surgery.
This trial tests a medication called esmolol (a short-acting beta-blocker) to see if it can improve blood flow in tiny blood vessels (microcirculation) and help stabilize blood pressure in people with septic shock who have a fast heart rate. The goal is to see if slowing the heart rate can improve organ function and recovery.
This study tests whether a medicine called esmolol, which slows the heart rate, can help people with septic shock (a severe infection that causes very low blood pressure) when their heart is beating too fast. Doctors will use ultrasound to make sure it's safe before giving the medicine.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.